Evidence map›Paper›PMID 31822523›Full record

ArticleThorax2020

GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation.

Soo Jung Cho, Jong-Seok Moon, Kiichi Nikahira, Ha Seon Yun, Rebecca Harris, Kyung Sook Hong, Huarong Huang, Augustine M K Choi, Heather Stout-Delgado

Open access · hybridAbstract read
In one paragraph

Article in Thorax, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Inflammasomes in respiratory diseases: from disease pathogenesis to drug development and use of multi-omics.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  3. Review
  4. Advances in metabolic reprogramming of pulmonary fibrosis.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Altered Metabolism in Idiopathic Pulmonary Fibrosis.Journal of cellular physiology · 2025
    Review
  12. Article
  13. Article
  14. Glycolysis-Related Genes,Cardiology research · 2025
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Soo Jung ChoMedicine, Weill Cornell Medical College, New York City, New York, USA.
Jong-Seok MoonDepartment of Integrated Biomedical Science, Soonchunhyang Institute of Medi-bio Science (SIMS), Soon Chun Hyang University, Asan, Chungcheongnam-do, Korea.
Kiichi NikahiraMedicine, Weill Cornell Medical College, New York City, New York, USA.
Ha Seon YunMedicine, Weill Cornell Medical College, New York City, New York, USA.
Rebecca HarrisMedicine, Weill Cornell Medical College, New York City, New York, USA.
Kyung Sook HongMedicine, Weill Cornell Medical College, New York City, New York, USA.
Huarong HuangMedicine, Weill Cornell Medical College, New York City, New York, USA.
Augustine M K ChoiMedicine, Weill Cornell Medical College, New York City, New York, USA.
Heather Stout-DelgadoMedicine, Weill Cornell Medical College, New York City, New York, USA hes2019@med.cornell.edu.
Cornell University · USSoonchunhyang University · KR

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI HERSH, CRAIG P · 2013 to 2025
$24.9M
Impact of Heightened UPR Activation on Inflammasome Responses to Influenza and Secondary Streptococcus pneumoniae Infection in Aged LungR01AG056699 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI STOUT DELGADO, HEATHER WINONA · 2018 to 2022
$2.6M
Impact of Heightened ER Stress on NLRP3 Activation in Aged Lung during InfectionR01AG052530 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI STOUT DELGADO, HEATHER WINONA · 2017 to 2021
$2.1M
GLUT1-dependent glycolysis regulates age-susceptible lung fibrosisK08HL138285 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHO, SOO JUNG · 2017 to 2021
$829k
NHLBI NIH HHS K08 HL138285NHLBI NIH HHS P01 HL114501NIA NIH HHS L30 AG057058NIA NIH HHS R01 AG052530NIA NIH HHS R01 AG056699
6 · The paper itself

Abstract

backgroundIdiopathic pulmonary fibrosis (IPF) is a rapidly progressive, fatal lung disease that affects older adults. One of the detrimental natural histories of IPF is acute exacerbation of IPF (AE-IPF), of which bacterial infection is reported to play an important role. However, the mechanism by which bacterial infection modulates the fibrotic response remains unclear.

objectivesAltered glucose metabolism has been implicated in the pathogenesis of fibrotic lung diseases. We have previously demonstrated that glucose transporter 1 (GLUT1)-dependent glycolysis regulates fibrogenesis in a murine fibrosis model. To expand on these findings, we hypothesised that GLUT1-dependent glycolysis regulates acute exacerbation of lung fibrogenesis during bacterial infection via AIM2 inflammasome activation.

resultsIn our current study, using a murine model of

conclusionOur results demonstrate that GLUT1-dependent glycolysis promotes exacerbation of lung fibrogenesis during

Indexed as

GlycolysisAnimalsBleomycinDisease Models, AnimalDisease ProgressionFibrosisGene Knockout TechniquesGlucose Transporter Type 1HumansIdiopathic Pulmonary FibrosisInflammasomesLungMicePneumococcal InfectionsBleomycinGlucose Transporter Type 1InflammasomesSlc2a1 protein, mouseidiopathic pulmonary fibrosisinterstitial fibrosispneumonia

Identifiers

PMID31822523
PMCPMC7063401
OpenAlexW2970882455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.